1117142

Niagara Pharmaceuticals Inc — FEI 3003093882

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 7, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dundas (Canada)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
202721 CFR 211.192Investigations of discrepancies, failures